DIALYSIS · CCN 332706

FMC AVANTUS HARLEM GREEN DIALYSIS

NEW YORK, NY 10027

DialysisProfitFresenius Medical Care
$8.3M
TOTAL REVENUE
11.4%
OPERATING MARGIN
5 / 5
STAR RATING
15
QUALITY MEASURES
Fresenius Medical Care
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$8.3M
Total costs
$7.3M
Operating income (rev − costs)
$942K
Operating margin
11.4%
Total charges
$8.3M
Total treatments
23,769
Dialysis stations
32

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

15 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
97204—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.6771—
Fistula Rate
DFC_FISTULA_RATE
62214—
Five Star Rating
DFC_FIVE_STAR
5——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
2.5473—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
150150—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
0209—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.45——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
12214—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
18.7621—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
22.6170—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
27.9182—
Standardized ED Visits Ratio
DFC_SEDR
0.548—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
12.744—